Tharimmune Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
CNTN$2.06+6.7%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current assets | ||
| Cash | $8,427,290 | $10,935,352 |
| Prepaid expenses and other current assets | 460,007 | 11,041 |
| Total current assets | 8,887,297 | 10,946,393 |
| Total assets | $8,887,297 | $10,946,393 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $993,244 | $908,577 |
| Accrued expenses | 527,527 | 906,469 |
| Insurance premium financing liability | 317,119 | - |
| Total current liabilities | 1,837,890 | 1,815,046 |
| Total liabilities | 1,837,890 | 1,815,046 |
| Commitments and contingencies (see Note 5) | - | - |
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023 | - | - |
| Common stock, $0.0001 par value, 250,000,000 shares authorized, 11,793,309 shares and 11,743,309 shares issued and 11,789,676 shares and 11,739,676 shares outstanding as of March 31, 2024 and December 31, 2023, respectively | 1,180 | 1,175 |
| Additional paid-in capital | 34,077,827 | 33,903,663 |
| Accumulated deficit | (26,959,635) | (24,703,526) |
| Treasury stock, at cost, 3,633 shares held in treasury as of March 31, 2024 and December 31, 2023 | (69,965) | (69,965) |
| Total stockholders’ equity | 7,049,407 | 9,131,347 |
| Total liabilities and stockholders’ equity | $8,887,297 | $10,946,393 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.